This Phase II trial tests the safety and potential benefits of AZD6234 for people with overweight or obesity and Type 2 Diabetes already using a GLP-1 receptor agonist. The goal is to see whether AZD6234 can support better weight and blood sugar control. Participants will continue their current treatment while also receiving the study drug or a placebo.
Eligibility:
• Ages 18–75
• Diagnosed with Type 2 Diabetes
• Currently using a GLP-1 medication and not using insulin
This study explores a new endoscopic procedure to help manage type 2 diabetes in people whose condition isn’t well-controlled with current non-insulin medications. Researchers aim to determine whether this therapy is safe and effective in improving blood sugar levels. Participants must meet specific health criteria and be willing to follow study requirements, including certain medication restrictions and preparation for procedures.
Eligibility:
• Ages 22–70
• Diagnosed with Type 2 Diabetes
• Not currently using insulin
We understand that enrolling in a clinical trial can raise many questions. How long will the trial last? Are there costs involved? What happens if the treatment doesn’t work for me? Our comprehensive FAQ section is here to address these concerns and more, empowering you with the knowledge you need to make an informed decision. Our goal is to provide answers with empathy and honesty, ensuring you feel supported at every stage of your trial participation. For further details or specific concerns, Read More FAQs to explore all the insights available.
Headquarters
The Pavilion at Doral
3650 NW 82nd Ave, PH 503
Suite 208
Doral, FL 33166
Tel: (305) 677-9267
Fax: (305) 503-9363
